ALLY vs ARCC

Ally Financial exhibits a stable health profile with a Piotroski F-Score of 4/9 and is significantly undervalued relative to its Graham Number ($47.52) and Intrinsic Value ($69.33). The company shows explosive earnings growth (265.4% YoY) and a highly attractive Forward P/E of 6.67 and PEG of 0.47. While low ROE (5.8%) and a bearish technical trend (0/100) present short-term headwinds, the fundamental valuation gap provides a substantial margin of safety. The stock is currently trading below book value (P/B 0.99), suggesting a strong entry point for value-oriented investors.

ARCC presents a conflicting profile: while it trades at a discount to book value (P/B 0.93) and below its Graham Number ($28.81), its fundamental health is deteriorating. The Piotroski F-Score of 2/9 indicates weak financial health, compounded by a concerning earnings decline of -24.90% YoY. Most critically, the dividend payout ratio of 103.23% suggests the current 10.32% yield is unsustainable without eroding capital or utilizing reserves. Despite analyst 'Buy' ratings, the combination of negative growth and poor deterministic health scores warrants a cautious approach.